CCL2 and acute myeloid leukemia: Moreover, the level of CCL2 is a prognostic marker for AML, with higher serum levels of this chemokine detected in untreated AML individuals possessing unfavourable cytogenetics when compared to patients with favourable cytogenetics (Mazur et al., 2007).